Interestingly, BRCA1-, but not BRCA2-, deficient breast cancers were observed to be associated with higher expression of PD-L1 and PD-1, and increased abundance of tumour-infiltrating immune cells involved in adaptive immune response. Here, CD274 is linked to neoplasm.